Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      With Vildagliptin off-patent from today, new doors open for pharma players

      With Vildagliptin off-patent from today, new doors open for pharma players

      Farhat Nasim10 Dec 2019 12:47 PM IST
      New Delhi: The expiry of Swiss-drugmaker Novartis's blockbuster anti-diabetic drug Vildagliptin is being a bringer of glad tidings for Indian Pharma...
      Sun Pharma arm-SPARC updates on Paclitaxel Injection Concentrate for Suspension litigation

      Sun Pharma arm-SPARC updates on Paclitaxel Injection Concentrate for Suspension litigation

      Farhat Nasim9 Dec 2019 3:56 PM IST
      "Abraxis Biosciences LLC has dismissed the patent infringement complaint filed against Sun Pharma Advanced Research Co Ltd regarding SPARC's New Drug...
      Solara Active Pharma names Bharath R Sesha as new CEO

      Solara Active Pharma names Bharath R Sesha as new CEO

      Farhat Nasim9 Dec 2019 3:15 PM IST
      "The Board of Directors, on the recommendation of Nomination and Remuneration Committee, have appointed Bharath R Sesha as Chief Executive Officer of...
      CDSCO directs Veterinary manufacturers to submit Periodic Safety Reports every 6 months for first 2 years

      CDSCO directs Veterinary manufacturers to submit Periodic Safety Reports every 6 months for first 2 years

      Farhat Nasim9 Dec 2019 12:12 PM IST
      The direction to submit PSURs came after various stakeholders of Veterinary products raised a concern regarding the clarification with respect to...
      GAVI to invest USD 178 million for creating Ebola vaccine stockpile

      GAVI to invest USD 178 million for creating Ebola vaccine stockpile

      Farhat Nasim9 Dec 2019 9:30 AM IST
      Since the latest outbreak in Congo was identified last August, health officials have immunised more than 255, 000 people with a recently licensed...
      Govt action against BioMed contaminated polio vaccine supply; Minister informs RS

      Govt action against BioMed contaminated polio vaccine supply; Minister informs RS

      Farhat Nasim8 Dec 2019 11:30 AM IST
      New Delhi: The Minister in the Ministry of Health and Family Welfare, Ashwini Kumar Choubey recently informed the Parliament about the action taken by...
      Dabur eyes to acquire firms, expand in rural India with Rs 3500 crore war chest: Report

      Dabur eyes to acquire firms, expand in rural India with Rs 3500 crore war chest: Report

      Farhat Nasim8 Dec 2019 9:45 AM IST
      “We have a ready war chest available to acquire companies,” Malhotra said, adding that Dabur has reserves of up to 35 billion rupees ($490 million)....
      How to make Medical Devices Affordable- Minister apprises Lok Sabha

      How to make Medical Devices Affordable- Minister apprises Lok Sabha

      Farhat Nasim6 Dec 2019 3:00 PM IST
      New Delhi: Through a written reply, the Minister in the Ministry of Chemicals and Fertilizers D V Sadananda Gowda recently apprised the Parliament...
      FIRST: Mankind Pharma unveils infertility drug Dydrogesterone in India

      FIRST: Mankind Pharma unveils infertility drug Dydrogesterone in India

      Farhat Nasim6 Dec 2019 11:04 AM IST
      With the launch of generic Dydrogesterone tablets, Mankind Pharma has become the first Indian and second global firm to develop the drug for the...
      Govt puts a FULL STOP on E-pharmacies running without licences, directs necessary action

      Govt puts a FULL STOP on E-pharmacies running without licences, directs necessary action

      Farhat Nasim5 Dec 2019 12:55 PM IST
      New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organisation's (CDSCO) recently issued orders to impose a ban on unlicensed...
      Caplin Point subsidiary receives USFDA approval for Sodium Nitroprusside injection to reduce BP

      Caplin Point subsidiary receives USFDA approval for Sodium Nitroprusside injection to reduce BP

      Farhat Nasim4 Dec 2019 9:50 AM IST
      The product is a generic therapeutic equivalent version of NITROPRESS (Sodium Nitroprusside) 50 mg/vial of Hospira Worldwide, INC, Caplin said in a...
      Zydus Cadila gets tentative USFDA nod for Lorcaserin Hydrochloride Tablets to treat obesity

      Zydus Cadila gets tentative USFDA nod for Lorcaserin Hydrochloride Tablets to treat obesity

      Farhat Nasim4 Dec 2019 9:30 AM IST
      Lorcaserin Hydrochloride Tablets will be manufactured at the group’s formulations manufacturing facility at $132, Zydus Cadila said in a filing.New...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok